Amerisource Bergen said on August 2, 2023 that its board of directors declared a regular quarterly dividend of $0.48 per share ($1.94 annualized). Previously, the company paid $0.48 per share.
Shareholders of record as of August 11, 2023 will receive the payment on August 28, 2023.
At the current share price of $185.72 / share, the stock's dividend yield is 1.04%.
Looking back five years and taking a sample every week, the average dividend yield has been 1.59%, the lowest has been 1.01%, and the highest has been 2.27%. The standard deviation of yields is 0.31 (n=236).
The current dividend yield is 1.77 standard deviations below the historical average.
Additionally, the company's dividend payout ratio is 0.23. The payout ratio tells us how much of a company's income is paid out in dividends. A payout ratio of one (1.0) means 100% of the company's income is paid in a dividend. A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Companies with few growth prospects are expected to pay out most of their income in dividends, which typically means a payout ratio between 0.5 and 1.0. Companies with good growth prospects are expected to retain some earnings in order to invest in those growth prospects, which translates to a payout ratio of zero to 0.5.
The company's 3-Year dividend growth rate is 0.15%, demonstrating that it has increased its dividend over time.
What is the Fund Sentiment?
There are 1873 funds or institutions reporting positions in Amerisource Bergen. This is an increase of 22 owner(s) or 1.19% in the last quarter. Average portfolio weight of all funds dedicated to ABC is 0.36%, a decrease of 10.84%. Total shares owned by institutions increased in the last three months by 0.94% to 177,556K shares. 
The put/call ratio of ABC is 0.94, indicating a bullish outlook.
Analyst Price Forecast Suggests 9.29% Upside
As of August 2, 2023, the average one-year price target for Amerisource Bergen is 202.98. The forecasts range from a low of 177.76 to a high of $223.65. The average price target represents an increase of 9.29% from its latest reported closing price of 185.72.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Amerisource Bergen is 254,287MM, a decrease of 0.05%. The projected annual non-GAAP EPS is 11.60.
What are Other Shareholders Doing?
Price T Rowe Associates holds 10,257K shares representing 5.07% ownership of the company. In it's prior filing, the firm reported owning 4,171K shares, representing an increase of 59.33%. The firm increased its portfolio allocation in ABC by 121.10% over the last quarter.
Jpmorgan Chase holds 7,002K shares representing 3.46% ownership of the company. In it's prior filing, the firm reported owning 6,503K shares, representing an increase of 7.13%. The firm decreased its portfolio allocation in ABC by 3.86% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 5,323K shares representing 2.63% ownership of the company. In it's prior filing, the firm reported owning 4,999K shares, representing an increase of 6.08%. The firm decreased its portfolio allocation in ABC by 5.00% over the last quarter.
Boston Partners holds 5,011K shares representing 2.48% ownership of the company. In it's prior filing, the firm reported owning 5,201K shares, representing a decrease of 3.80%. The firm decreased its portfolio allocation in ABC by 63.09% over the last quarter.
VIMSX - Vanguard Mid-Cap Index Fund Investor Shares holds 4,015K shares representing 1.99% ownership of the company. In it's prior filing, the firm reported owning 3,831K shares, representing an increase of 4.60%. The firm decreased its portfolio allocation in ABC by 1.96% over the last quarter.
Amerisource Bergen Background Information
(This description is provided by the company.)
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work-and powered by our 22,000 associates-we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $185 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries.
Additional reading:
- ABC / Amerisource Bergen Corp. / Walgreens Boots Alliance, Inc. - EX-99.22
- ABC / Amerisource Bergen Corp. / Walgreens Boots Alliance, Inc. - EX-99.24
- AMERISOURCEBERGEN REPORTS FISCAL 2023 THIRD QUARTER RESULTS Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $2.35 and Adjusted Diluted EPS of $2.92 Adjusted Diluted EPS Guidanc
- Share Repurchase Agreement, dated as of June 15, 2023, by and between AmerisourceBergen Corporation and Walgreens Boots Alliance Holdings LLC.
- SHARE REPURCHASE AGREEMENT
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
